Finally, we evaluated whether targeting the PI3K–AKT–mTOR signaling by the pan-PI3K inhibitor pictilisib could impede the MM-supporting function of MM-associated MSCs. The gene discussed is AKT1; the disease is Miyoshi myopathy.